Author information:
(1)Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; 
Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
(2)Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
(3)Centre for Cancer Genetic Epidemiology, Department of Public Health and 
Primary Care, University of Cambridge, Cambridge, United Kingdom.
(4)Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
(5)Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, 
Spain.
(6)IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
(7)Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute 
of Oncology, Barcelona, Spain.
(8)Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, 
Spain.
(9)Institute of Biology and Molecular Genetics, Universidad de Valladolid 
(IBGM-UVA), Valladolid, Spain.
(10)Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron 
Institute of Oncology (VHIO), Vall d'Hebron Institut de Recerca (VHIR), and 
Universitat Autonoma de Barcelona, Barcelona, Spain.
(11)Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
(12)Molecular Diagnostics Laboratory IRRP, National Centre for Scientific 
Research Demokritos Aghia Paraskevi Attikis, Athens, Greece.
(13)Molecular Genetics Laboratory (Department of Biochemistry), Cruces Hospital 
Barakaldo, Bizkaia, Spain.
(14)Medical Oncology Service, Hospital Clínico Lozano Blesa, San Juan Bosco, 
Zaragoza, Spain.
(15)Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and 
Laval University, Quebec City, Canada.
(16)Department of Oncology, Lund University, Lund, Sweden.
(17)Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
(18)Department of Clinical Genetics, Karolinska University Hospital, Stockholm, 
Sweden.
(19)Department of Oncology, Lund University Hospital, Lund, Sweden.
(20)Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
(21)Center for Clinical Cancer Genetics and Global Health, University of Chicago 
Medical Center, Chicago, Illinois, United States of America.
(22)Departments of Medicine, Epidemiology, and Biostatistics, University of 
California, San Francisco, San Francisco, California, United States of America.
(23)Abramson Cancer Center and Department of Medicine, The University of 
Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of 
America.
(24)Abramson Cancer Center and Center for Clinical Epidemiology and 
Biostatistics, The University of Pennsylvania Perelman School of Medicine, 
Philadelphia, Pennsylvania, United States of America.
(25)University of Texas MD Anderson Cancer Center, Houston, Texas, United States 
of America.
(26)Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, 
Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
(27)Department of Epidemiology, Cancer Prevention Institute of California, 
Fremont, California, United States of America.
(28)Department of Health Research & Policy, Stanford University School of 
Medicine, Stanford, California, United States of America.
(29)Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of 
America.
(30)Genetic Epidemiology Laboratory, Department of Pathology, University of 
Melbourne, Parkville, Australia.
(31)Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, 
University of Melbourne, Melbourne, Victoria, Australia.
(32)Department of Epidemiology, Columbia University, New York, New York, United 
States of America.
(33)Department of Oncological Sciences, Huntsman Cancer Institute, University of 
Utah School of Medicine, Salt Lake City, Utah, United States of America.
(34)Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and 
transfusion medicine center, Department of Molecular and Regenerative Medicine, 
Vilnius, Lithuania.
(35)Department of Genetics, University of Pretoria, Pretoria, South Africa.
(36)Department of Population Sciences, Beckman Research Institute of City of 
Hope, Duarte, California, United States of America.
(37)Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, 
Copenhagen, Denmark.
(38)Department of Oncology, Rigshospitalet, University of Copenhagen, 
Copenhagen, Denmark.
(39)Department of Clinical Genetics, Rigshospitalet, University of Copenhagen, 
Copenhagen, Denmark.
(40)Clinical Cancer Genetics, City of Hope, Duarte, California, United States of 
America.
(41)Unit of Medical Genetics, Department of Preventive and Predictive Medicine, 
Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
(42)Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, 
Milan, Italy.
(43)IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer 
Genetic Test Laboratory, Milan, Italy.
(44)Division of Experimental Oncology 1, Centro di Riferimento Oncologico, 
IRCCS, Aviano, Italy.
(45)Unit of Hereditary Cancer, Department of Epidemiology, Prevention and 
Special Functions, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca 
sul Cancro, Genoa, Italy.
(46)Unit of Medical Genetics, Department of Biomedical, Experimental and 
Clinical Sciences, University of Florence, Florence, Italy.
(47)Department of Molecular Medicine, "Sapienza" University, Rome, Italy.
(48)UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, 
Varese, Italy.
(49)Unit of Molecular bases of genetic risk and genetic testing, Department of 
Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori 
(INT), Milan, Italy.
(50)Dana-Farber Cancer Institute, Boston, Massachusetts, United States of 
America.
(51)Genetic Medicine, Manchester Academic Health Sciences Centre, Central 
Manchester University Hospitals NHS Foundation Trust, Manchester, United 
Kingdom.
(52)South East Thames Regional Genetics Service, Guy's Hospital London, United 
Kingdom.
(53)Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS 
Foundation Trust, London, United Kingdom.
(54)Yorkshire Regional Genetics Service, Leeds, United Kingdom.
(55)Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, 
United Kingdom.
(56)West Midlands Regional Genetics Service, Birmingham Women's Hospital 
Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom.
(57)Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, 
United Kingdom.
(58)Sheffield Clinical Genetics Service, Sheffield Children's Hospital, 
Sheffield, United Kingdom.
(59)Clinical Genetics Department, St Georges Hospital, University of London, 
London, United Kingdom.
(60)Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, 
United Kingdom.
(61)Department of Clinical Genetics, East Anglian Regional Genetics Service, 
Addenbrookes Hospital, Cambridge, United Kingdom.
(62)Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals 
NHS Trust, Newcastle upon Tyne, United Kingdom.
(63)South East of Scotland Regional Genetics Service, Western General Hospital, 
Edinburgh, United Kingdom.
(64)North East Thames Regional Genetics Service, Great Ormond Street Hospital 
for Children NHS Trust, London, United Kingdom.
(65)Oxford Regional Genetics Service, Churchill Hospital, Oxford, United 
Kingdom.
(66)Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, 
United Kingdom.
(67)South West Regional Genetics Service, Bristol, United Kingdom.
(68)Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and 
St James's Hospital, Dublin, Eire.
(69)Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS 
Foundation Trust, Liverpool, United Kingdom.
(70)Department of Pathology and Laboratory Medicine, University of Kansas 
Medical Center, Kansas City, Kansas, United States of America.
(71)Centre of Familial Breast and Ovarian Cancer and Centre for Integrated 
Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
(72)Institute for Medical Informatics, Statistics and Epidemiology, University 
of Leipzig, Leipzig, Germany.
(73)Department of Gynaecology and Obstetrics, Division of Tumor Genetics, 
Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
(74)Department of Gynecology and Obstetrics, University Medical Center 
Schleswig-Holstein, Campus Kiel, Kiel, Germany.
(75)Institute of Human Genetics, University Medical Center Schleswig-Holstein, 
Campus Kiel, Kiel, Germany.
(76)Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, 
Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
(77)Institute of Human Genetics, Department of Human Genetics, University 
Hospital Heidelberg, Heidelberg, Germany.
(78)Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, 
Germany.
(79)Institute of Cell and Molecular Pathology, Hannover Medical School, 
Hannover, Germany.
(80)Institute of Human Genetics, University of Münster, Münster, Germany.
(81)Department of Gynaecology and Obstetrics, University Hospital Carl Gustav 
Carus, Technical University Dresden, Dresden, Germany.
(82)Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, 
Berlin, Germany.
(83)Centre of Familial Breast and Ovarian Cancer, Department of Medical 
Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
(84)Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, 
INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, 
Paris, France.
(85)Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices 
Civils de Lyon - Centre Léon Bérard, Lyon, France; INSERM U1052, CNRS UMR5286, 
Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
(86)INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en 
Cancérologie de Lyon, Lyon, France.
(87)Center for Medical Genetics, Ghent University, Ghent, Belgium.
(88)Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer 
Institute, Buffalo, New York, United States of America.
(89)Prince of Wales Hospital. Sydney, Australia.
(90)Ohio State University, Columbus Cancer Council, Columbus, Ohio, United 
States of America.
(91)Division of Gynecologic Oncology, NorthShore University HealthSystem, 
Evanston, Illinois, United States of America.
(92)Division of Gynecologic Oncology, NorthShore University HealthSystem, 
Chicago, Illinois, United States of America.
(93)For Tufts Medical Center, Boston, Massachusetts, United States of America.
(94)Yale University School of Medicine, New Haven, Connecticut, United States of 
America.
(95)Department of Obstetrics and Gynecology, University of Helsinki and Helsinki 
University Central Hospital, Helsinki, Finland.
(96)Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The 
Netherlands.
(97)Department of Clinical Genetics, Academic Medical Center, Amsterdam, The 
Netherlands.
(98)Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The 
Netherlands.
(99)Department of Clinical Genetics, VU University Medical Centre, Amsterdam, 
The Netherlands.
(100)University of Groningen, University Medical Center Groningen, Department of 
Genetics, Groningen, The Netherlands.
(101)Department of Clinical Genetics, Leiden University Medical Center Leiden, 
Leiden, The Netherlands.
(102)Department of Clinical Genetics and GROW, School for Oncology and 
Developmental Biology, MUMC, Maastricht, The Netherlands.
(103)Department of Human Genetics, Radboud University Nijmegen Medical Centre, 
Nijmegen, The Netherlands.
(104)Department of Clinical Genetics, Family Cancer Clinic, Erasmus University 
Medical Center, Rotterdam, The Netherlands.
(105)Department of Pathology, Family Cancer Clinic, Erasmus University Medical 
Center, Rotterdam, The Netherlands.
(106)Department of Medical Genetics, University Medical Center Utrecht, Utrecht, 
The Netherlands.
(107)Department of Human Genetics & Department of Pathology, Leiden University 
Medical Center, Leiden, The Netherlands.
(108)The Hereditary Breast and Ovarian Cancer Research Group, Netherlands Cancer 
Institute, Amsterdam, The Netherlands.
(109)Department of Molecular Genetics, National Institute of Oncology, Budapest, 
Hungary.
(110)Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan 
Institute of Oncology, Barcelona, Spain.
(111)Department of Genetics and Pathology, Pomeranian Medical University, 
Szczecin, Poland.
(112)Department of Genetics and Pathology, Pomeranian Medical University, 
Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical 
University, Warsaw, Poland.
(113)Department of Oncology, Landspitali University Hospital and BMC, Faculty of 
Medicine, University of Iceland, Reykjavik Iceland.
(114)Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux 
Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France.
(115)Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - 
IRCCS, Padua, Italy.
(116)Department of Genetics, Portuguese Oncology Institute, Porto, and 
Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
(117)Department of Genetics and Computational Biology, Queensland Institute of 
Medical Research, Brisbane, Australia.
(118)Kathleen Cuningham Consortium for Research into Familial Breast Cancer, 
Peter MacCallum Cancer Center, Melbourne, Australia.
(119)Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, 
United States of America.
(120)Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, 
Minnesota, United States of America.
(121)Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, 
United States of America.
(122)Center for Translational Cancer Research, Department of Biological 
Sciences, University of Delaware, Newark, Delaware, United States of America.
(123)Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New 
York, New York, United States of America; Cancer Biology and Genetics Program, 
Memorial Sloan-Kettering Cancer Center, New York, New York, United States of 
America.
(124)Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New 
York, New York, United States of America.
(125)Diagnostic Molecular Genetics Laboratory, Memorial Sloan-Kettering Cancer 
Center, New York, New York, United States of America.
(126)Department of OB/GYN and Comprehensive Cancer Center, Medical University of 
Vienna, Vienna, Austria.
(127)Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, 
United States of America.
(128)Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, 
National Cancer Institute, National Institutes of Health, Rockville, Maryland, 
United States of America.
(129)Clalit National Israeli Cancer Control Center, Haifa, Israel.
(130)Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, 
Ontario, Canada, and Cancer Care Ontario, Departments of Molecular Genetics and 
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, 
Canada.
(131)Department of Laboratory Medicine and Pathobiology, University of Toronto, 
Toronto, Ontario, Canada; Laboratory Medicine Program, University Health 
Network, Toronto, Ontario, Canada.
(132)Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount 
Sinai Hospital, Toronto, Ontario, Canada.
(133)Division of Human Cancer Genetics, Departments of Internal Medicine and 
Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer 
Center, The Ohio State University, Columbus, Ohio, United States of America.
(134)Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
(135)Section of Molecular Diagnostics, Department of Clinical Biochemistry, 
Aalborg University Hospital, Aalborg, Denmark.
(136)Department of Clinical Genetics, Aarhus University Hospital, Aarhus, 
Denmark.
(137)Department of Clinical Genetics, Odense University Hospital, Odense, 
Denmark.
(138)Sheba Medical Center, Tel Aviv, Israel.
(139)Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre 
Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada.
(140)Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, 
United States of America; Department of Laboratory Medicine and Pathology, Mayo 
Clinic, Rochester, Minnesota, United States of America.
(141)Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; 
Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Genotyping Unit 
(CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain.